Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 HKD | +1.95% | 0.00% | -21.23% |
May. 02 | Alphamab Oncology's 2023 Loss Narrows as Revenue Rises | MT |
Apr. 10 | Alphamab Oncology Presents Phase-I Clinical Trial Results at 2024 AACR Annual Meeting | MT |
Sales 2023 | 219M 30.28M 237M | Sales 2024 * | 239M 33.1M 259M | Capitalization | 4.54B 629M 4.92B |
---|---|---|---|---|---|
Net income 2023 | -211M -29.21M -228M | Net income 2024 * | -299M -41.39M -323M | EV / Sales 2023 | 22.8 x |
Net cash position 2023 | 829M 115M 896M | Net cash position 2024 * | 585M 80.92M 632M | EV / Sales 2024 * | 16.6 x |
P/E ratio 2023 |
-27.4
x | P/E ratio 2024 * |
-15.6
x | Employees | 435 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 49.21% |
1 day | +1.95% | ||
Current month | +10.11% | ||
1 month | +11.28% | ||
3 months | +22.77% | ||
6 months | -58.56% | ||
Current year | -21.23% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Jing Han
CMP | Compliance Officer | 51 | 21-11-01 |
Jinbo Wang
CTO | Chief Tech/Sci/R&D Officer | 50 | 18-03-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Wei
BRD | Director/Board Member | 56 | 19-11-23 |
Ting Xu
CEO | Chief Executive Officer | 51 | 08-10-31 |
Yang Liu
COO | Chief Operating Officer | 52 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.21% | 4 M€ | -27.92% | ||
0.06% | 2 M€ | -14.14% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +3.95% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 5.23 | +1.95% | 1,944,000 |
24-05-09 | 5.13 | +3.01% | 2,792,000 |
24-05-08 | 4.98 | -1.19% | 1,565,000 |
24-05-07 | 5.04 | -2.51% | 3,128,700 |
24-05-06 | 5.17 | -0.39% | 2,749,300 |
Delayed Quote Hong Kong S.E., May 10, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.23% | 629M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 9966 Stock